← Back to Health Technology

Pharmaceuticals: Other

Industry Overview

Stock Screener

Select filters to narrow down the 3 companies below

3 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

PT Kalbe Farma Tbk

PTKFF

PT Kalbe Farma Tbk

PTKFF
Market Cap $2.37B
Dividends 2.5%
P/E Ratio 10.2
Revenue $9.87T +19.9%
Net Income $897B -0.1%
Profit Margin +9.1%
View Stock

Cipher Pharmaceuticals Inc.

CPHRF

Cipher Pharmaceuticals Inc.

CPHRF
Market Cap $263.31M
Dividends 0.0%
P/E Ratio 9.0
Revenue $11.8M -12.1%
Net Income $3.91M -33.6%
Profit Margin +33.3%
View Stock

Portola Pharmaceuticals, Inc.

PTLA

Portola Pharmaceuticals, Inc.

PTLA
Market Cap $
Dividends
P/E Ratio 0.0
Revenue $26.4M
Net Income -$68.8M
Profit Margin -260.6%
Employees 408
View Stock